These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20160709)

  • 21. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
    Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
    J Virol; 2018 May; 92(9):. PubMed ID: 29491162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
    Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
    Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase.
    Murray JM; Emery S; Kelleher AD; Law M; Chen J; Hazuda DJ; Nguyen BY; Teppler H; Cooper DA
    AIDS; 2007 Nov; 21(17):2315-21. PubMed ID: 18090280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay.
    Châtel L; Yang X; Cholette F; Soudeyns H; Sandstrom P; Lavigne C
    Arch Virol; 2018 Oct; 163(10):2701-2710. PubMed ID: 29882046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection.
    Müller V; Vigueras-Gómez JF; Bonhoeffer S
    J Virol; 2002 Sep; 76(17):8963-5. PubMed ID: 12163616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tests identify HIV's final redoubt.
    Cohen J
    Science; 2019 Mar; 363(6433):1260-1261. PubMed ID: 30898910
    [No Abstract]   [Full Text] [Related]  

  • 28. Nonlatching positive feedback enables robust bimodality by decoupling expression noise from the mean.
    Razooky BS; Cao Y; Hansen MMK; Perelson AS; Simpson ML; Weinberger LS
    PLoS Biol; 2017 Oct; 15(10):e2000841. PubMed ID: 29045398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of apoptosis and viral latency - an axis to be well understood for successful cure of human immunodeficiency virus.
    Timilsina U; Gaur R
    J Gen Virol; 2016 Apr; 97(4):813-824. PubMed ID: 26764023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient-mediated fate determination in a transcriptional circuit of HIV.
    Weinberger LS; Dar RD; Simpson ML
    Nat Genet; 2008 Apr; 40(4):466-70. PubMed ID: 18344999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residual Viremia in Treated HIV+ Individuals.
    Conway JM; Perelson AS
    PLoS Comput Biol; 2016 Jan; 12(1):e1004677. PubMed ID: 26735135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the architecture of the HIV-1 Tat circuit: A decision-making circuit that lacks bistability and exploits stochastic noise.
    Razooky BS; Weinberger LS
    Methods; 2011 Jan; 53(1):68-77. PubMed ID: 21167940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular virology founded models of anti-HIV therapy].
    Schröder HC; Müller WE
    Fortschr Med; 1994 Nov; 112(31):438-43. PubMed ID: 7528706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.
    Stevens M; Balzarini J; Tabarrini O; Andrei G; Snoeck R; Cecchetti V; Fravolini A; De Clercq E; Pannecouque C
    J Antimicrob Chemother; 2005 Nov; 56(5):847-55. PubMed ID: 16150861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomal Tat protein activates latent HIV-1 in primary, resting CD4+ T lymphocytes.
    Tang X; Lu H; Dooner M; Chapman S; Quesenberry PJ; Ramratnam B
    JCI Insight; 2018 Apr; 3(7):. PubMed ID: 29618654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
    Sedaghat AR; Siliciano RF; Wilke CO
    BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission.
    Guo T; Qiu ZP
    Math Biosci Eng; 2019 Jul; 16(6):6822-6841. PubMed ID: 31698590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal control in HIV chemotherapy with termination viral load and latent reservoir.
    Olabode D; Rong L; Wang X
    Math Biosci Eng; 2019 Jan; 16(2):619-635. PubMed ID: 30861659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of stochastic gene expression by host factors at the HIV promoter.
    Burnett JC; Miller-Jensen K; Shah PS; Arkin AP; Schaffer DV
    PLoS Pathog; 2009 Jan; 5(1):e1000260. PubMed ID: 19132086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.